TECH
Price
$62.95
Change
+$0.86 (+1.39%)
Updated
Oct 3 closing price
Capitalization
9.67B
31 days until earnings call
XNCR
Price
$11.77
Change
-$0.05 (-0.42%)
Updated
Oct 3 closing price
Capitalization
843.04M
37 days until earnings call
Interact to see
Advertisement

TECH vs XNCR

Header iconTECH vs XNCR Comparison
Open Charts TECH vs XNCRBanner chart's image
Bio-Techne
Price$62.95
Change+$0.86 (+1.39%)
Volume$3.49M
Capitalization9.67B
Xencor
Price$11.77
Change-$0.05 (-0.42%)
Volume$540.91K
Capitalization843.04M
TECH vs XNCR Comparison Chart in %
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TECH vs. XNCR commentary
Oct 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TECH is a StrongBuy and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 04, 2025
Stock price -- (TECH: $62.95 vs. XNCR: $11.77)
Brand notoriety: TECH and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TECH: 140% vs. XNCR: 57%
Market capitalization -- TECH: $9.67B vs. XNCR: $843.04M
TECH [@Biotechnology] is valued at $9.67B. XNCR’s [@Biotechnology] market capitalization is $843.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TECH’s FA Score shows that 2 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • TECH’s FA Score: 2 green, 3 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TECH’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • TECH’s TA Score: 5 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both TECH and XNCR are a good buy in the short-term.

Price Growth

TECH (@Biotechnology) experienced а +21.41% price change this week, while XNCR (@Biotechnology) price change was +1.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

TECH is expected to report earnings on Nov 04, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($9.67B) has a higher market cap than XNCR($843M). TECH YTD gains are higher at: -12.227 vs. XNCR (-48.782). TECH has higher annual earnings (EBITDA): 217M vs. XNCR (-125.38M). XNCR has more cash in the bank: 444M vs. TECH (162M). XNCR has less debt than TECH: XNCR (67.9M) vs TECH (444M). TECH has higher revenues than XNCR: TECH (1.22B) vs XNCR (147M).
TECHXNCRTECH / XNCR
Capitalization9.67B843M1,147%
EBITDA217M-125.38M-173%
Gain YTD-12.227-48.78225%
P/E Ratio134.98N/A-
Revenue1.22B147M830%
Total Cash162M444M36%
Total Debt444M67.9M654%
FUNDAMENTALS RATINGS
TECH vs XNCR: Fundamental Ratings
TECH
XNCR
OUTLOOK RATING
1..100
2122
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
75
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
8797
PRICE GROWTH RATING
1..100
4641
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (5) in the Biotechnology industry is significantly better than the same rating for XNCR (75). This means that TECH’s stock grew significantly faster than XNCR’s over the last 12 months.

TECH's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as XNCR (100). This means that TECH’s stock grew similarly to XNCR’s over the last 12 months.

TECH's SMR Rating (87) in the Biotechnology industry is in the same range as XNCR (97). This means that TECH’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's Price Growth Rating (41) in the Biotechnology industry is in the same range as TECH (46). This means that XNCR’s stock grew similarly to TECH’s over the last 12 months.

XNCR's P/E Growth Rating (5) in the Biotechnology industry is in the same range as TECH (9). This means that XNCR’s stock grew similarly to TECH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TECHXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 10 days ago
72%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRKX8.980.14
+1.57%
Fidelity Strategic Real Return K6
GMVIX17.03N/A
N/A
Goldman Sachs Small/Mid Cap Equity Inv
USDCNY7.15N/A
N/A
United States Dollar - China Yuan
EURCNY8.35N/A
N/A
Euro - China Yuan
JPYAUD0.01N/A
N/A
Japan Yen - Australian Dollar